Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron J Scott

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Molecules (Basel, Switzerland)|February 5, 2021
[Cr<sup>III</sup><sub>8</sub>Ni<sup>II</sup><sub>6</sub>]<sup>n+</sup> Heterometallic Coordination CubesHelen M O'Connor, Sergio Sanz, Aaron J Scott, et al.
Plos One|November 2, 2017
Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse modelAaron J Scott, Eun-Kee Song, Stacey Bagby, et al.
Contemporary Clinical Trials Communications|February 23, 2023
Lessons learned from the pilot family model of diabetes self-management intervention in the Republic of the Marshall IslandsJennifer A Andersen, Rachel S Purvis, Aaron J Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2024
Management of Locally Advanced Rectal Cancer: ASCO GuidelineAaron J Scott, Erin B Kennedy, Jordan Berlin, et al.
Cancer Research Communications|February 5, 2025
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction CancersAndrew H Ko, Joseph Chao, Marcus S Noel, et al.
Molecular Cancer Therapeutics|July 21, 2018
Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling MechanismsAaron J Scott, John J Arcaroli, Stacey M Bagby, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer TherapyRachna T Shroff, Pavani Chalasani, Ran Wei, et al.
Nature Medicine|October 1, 2021
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumorsRachna T Shroff, Pavani Chalasani, Ran Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2024
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract CancersRachna T Shroff, Gentry King, Sarah Colby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
The Landscape of Alterations in DNA Damage Response Pathways in Colorectal CancerHiroyuki Arai, Andrew Elliott, Joanne Xiu, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Molecules (Basel, Switzerland)|February 5, 2021
[Cr<sup>III</sup><sub>8</sub>Ni<sup>II</sup><sub>6</sub>]<sup>n+</sup> Heterometallic Coordination CubesHelen M O'Connor, Sergio Sanz, Aaron J Scott, et al.
Plos One|November 2, 2017
Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse modelAaron J Scott, Eun-Kee Song, Stacey Bagby, et al.
Contemporary Clinical Trials Communications|February 23, 2023
Lessons learned from the pilot family model of diabetes self-management intervention in the Republic of the Marshall IslandsJennifer A Andersen, Rachel S Purvis, Aaron J Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2024
Management of Locally Advanced Rectal Cancer: ASCO GuidelineAaron J Scott, Erin B Kennedy, Jordan Berlin, et al.
Cancer Research Communications|February 5, 2025
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction CancersAndrew H Ko, Joseph Chao, Marcus S Noel, et al.
Molecular Cancer Therapeutics|July 21, 2018
Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling MechanismsAaron J Scott, John J Arcaroli, Stacey M Bagby, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer TherapyRachna T Shroff, Pavani Chalasani, Ran Wei, et al.
Nature Medicine|October 1, 2021
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumorsRachna T Shroff, Pavani Chalasani, Ran Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2024
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract CancersRachna T Shroff, Gentry King, Sarah Colby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
The Landscape of Alterations in DNA Damage Response Pathways in Colorectal CancerHiroyuki Arai, Andrew Elliott, Joanne Xiu, et al.
Pageof 6